Free shipping on all orders over $ 500

Omaveloxolone

Cat. No. M10081
Omaveloxolone Structure
Synonym:

RTA-408

Size Price Availability Quantity
10mM*1mL in DMSO USD 117  USD117 In stock
1mg USD 49  USD49 In stock
2mg USD 67  USD67 In stock
5mg USD 90  USD90 In stock
10mg USD 147  USD147 In stock
25mg USD 267  USD267 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control & Documentation
Biological Activity

Omaveloxolone (RTA 408) is a first-in-class antioxidant inflammatory modulator (AIM) that activates Nrf2 and inhibits nitric oxide (NO). Omaveloxolone inhibits osteoclastogenesis by inhibiting the STING-dependent NF-κb signaling pathway.

Omaveloxolone (RTA-408) is a member of the synthetic oleanane triterpenoid class of compounds and an activator of nuclear factor erythroid 2 [NF-E2]-related factor 2 (Nrf2). Omaveloxolone (RTA-408) potently increases expression of Nrf2 target genes and reverses IFNγ-mediated suppression of Gclc expression in RAW 264.7 cells. In a panel of eight human tumor cell lines, Omaveloxolone inhibits growth with an average GI50 value of 260 nM and induces apoptosis.

Product Citations
Chemical Information
Molecular Weight 554.71
Formula C33H44F2N2O3
CAS Number 1474034-05-3
Solubility (25°C) DMSO 90 mg/mL
Storage Powder          -20°C   3 years ;  4°C   2 years
In solvent       -80°C   6 months ;  -20°C   1 month
Conversion of different model animals based on BSA (PMID: 27057123)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

References

[1] Brandon L Probst, et al. PLoS One. RTA 408, A Novel Synthetic Triterpenoid with Broad Anticancer and Anti-Inflammatory Activity

[2] Devorah C Goldman, et al. Radiat Res. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice

[3] Scott A Reisman, et al. Radiat Res. Topical application of the synthetic triterpenoid RTA 408 protects mice from radiation-induced dermatitis

[4] Scott A Reisman, et al. Arch Dermatol Res. Topical application of the synthetic triterpenoid RTA 408 activates Nrf2 and induces cytoprotective genes in rat skin

Related Keap1-Nrf2 Products
TAT-14

TAT-14 is a 14-mer peptide that acts as Nrf2 activator with an anti-inflammatory effect.

[D-Asp3]-Microcystin-LR

Microcystin-[D-Asp3]-LR/Microcystin A is a cyanotoxin.

Keap1-Nrf2 probe

Keap1-Nrf2 probe is a fluorescent Keap1-Nrf2 probe.

BAY-3605349

BAY-3605349 is an orally active Kelch-like ECH-associated protein 1 (KEAP1) activator as well as Nrf2 inhibitor for tumor-related studies.

Nrf2/HO-1 activator 1

Nrf2/HO-1 activator 1 is a potent Nrf2/HO-1 activator, neuroprotective agent.

  Catalog
Abmole Inhibitor Catalog




Keywords: Omaveloxolone, RTA-408 supplier, Keap1-Nrf2, inhibitors, activators


Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2023 AbMole BioScience. All Rights Reserved.